Clinical Development Gene Silencing Pharma Companies Vaccination 
pharmaphorum
DECEMBER 23, 2020
It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. Pharma companies have also made headway in rare diseases as several pipeline projects came to fruition. Rare disease progress.
Drug Discovery World
OCTOBER 4, 2022
As it stands, there are currently 19 gene therapies approved for clinical use, alongside 18 RNA therapies and 59 non-genetically modified cell therapies, according to the Q2 report by the American Society of Cell & Gene Therapy. This year has seen some major deals announced by big pharma companies.
Expert insights. Personalized for you.
78 
Let's personalize your content